[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase

[Asia Economy Reporter Hwang Junho] Daebong LS is surging on news of a free capital increase by its subsidiary, P&K Skin Clinical Research Center.

As of 10:14 AM on the 12th, Daebong LS is trading at 8,790 KRW, up 16.27% from the previous day.

On the same morning, P&K Skin Clinical Research Center announced a decision to issue three free shares for every one common share. Trading of this stock was suspended for 30 minutes from the time of the announcement due to the disclosure of major matters.

Daebong LS is the largest shareholder, holding 54.74% of P&K Skin Clinical Research Center's shares.

This content was produced with the assistance of AI translation services.